Prelude Therapeutics Incorporated – Filings and Transcripts

NASDAQ: PRLD
Share price (6/11/26): $4.11
Market cap (6/11/26): $327 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Registration of securities for employees

Ownership Filter

Friedman Paul A

News Filter

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Announces Pricing of $90.0 Million Underwritten Offering

Data Demonstrate Potential for Differentiated Efficacy and Safety Profile, Including Complete Responses as Monotherapy in Multiple CDX and PDX Models of HR+/HER2- Breast Cancer

Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Notice of effectiveness